|
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia
|
18 January 2017 |
|
Aberrant retinoid signaling and breast cancer: the view from outside the nucleus
|
17 January 2017 |
|
1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis
|
17 January 2017 |
|
Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer
|
11 January 2017 |
|
Vitamin D in preventive medicine: are we ignoring the evidence?
|
20 December 2016 |
|
Circadian function in patients with advanced non-small-cell lung cancer
|
20 December 2016 |
|
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo
|
09 November 2016 |
|
Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2
|
01 November 2016 |
|
Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide
|
28 October 2016 |
|
Melatonin and vitamin D3 increase TGF-beta1 release and induce growth inhibition in breast cancer cell cultures
|
21 October 2016 |